Platelet-activating factor receptor

Prostaglandins and Other Lipid Mediators

Volumn 68-69, Issue , 2002, Pages 599-609

  Ishii, Satoshi ^a,b   Nagase, Takahide ^a   Shimizu, Takao ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Intracellular signaling pathways; Phospholipid mediator; Platelet activating factor

Indexed keywords

G PROTEIN COUPLED RECEPTOR; PHOSPHOLIPID; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; CELL SURFACE RECEPTOR; FIBRINOGEN RECEPTOR;

ANAPHYLAXIS; ARTICLE; BINDING AFFINITY; BRAIN; BRONCHUS HYPERREACTIVITY; CELL TYPE; DNA MODIFICATION; DRUG POTENCY; GENE FREQUENCY; GENE OVEREXPRESSION; GENE STRUCTURE; GENOMICS; HUMAN; INFLAMMATION; KNOCKOUT MOUSE; MEDIATOR; MOLECULAR CLONING; MOUSE MUTANT; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REPRODUCTION; SHOCK; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN; THROMBOCYTE AGGREGATION; ANIMAL; METABOLISM; PHYSIOLOGY; REVIEW; SEPTIC SHOCK;

ANIMALS; BRAIN; HUMANS; PLATELET ACTIVATING FACTOR; PLATELET MEMBRANE GLYCOPROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; SHOCK, SEPTIC; SIGNAL TRANSDUCTION; SKIN;

EID: 0036669418     PISSN: 00906980     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-6980(02)00058-8     Document Type: Article

References (78)

1. Benveniste J., Henson P.M., Cochrane C.G. Leukocyte-dependent histamine release from rabbit platelets: the role of IgE, basophils and a platelet-activating factor. J. Exp. Med. 136:1972;1356.
2. Demopoulos C.A., Pinckard R.N., Hanahan D.J. Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators). J. Biol. Chem. 254:1979;9355.
3. Blank M.L., Snyder F., Byers L.W., Brooks B., Muirhead E.E. Antihypertensive activity of an alkyl ether analog of phosphatidylcholine. Biochem. Biophys. Res. Commun. 90:1979;1194.
4. Benveniste J., Tence M., Varenne P., Bidault J., Boullet C., Polonsky J. Semi-synthesis and proposed structure of platelet-activating factor (PAF): PAF-acether an alkyl ether analog of lysophosphatidylcholine. C. R. Acad. Sci. D. 289:1979;1037.
5. Hanahan D.J. Platelet activating factor: a biologically active phosphoglyceride. Annu. Rev. Biochem. 55:1986;483.
6. Chao W., Olson M.S. Platelet-activating factor: receptors and signal transduction. Biochem. J. 292:1993;617.
7. Snyder F. The ether lipid trail: a historical perspective. Biochim. Biophys. Acta. 1436:1999;265.
8. Shimizu T., Honda Z., Nakamura M., Bito H., Izumi T. Platelet-activating factor receptor and signal transduction. Biochem. Pharmacol. 44:1992;1001.
9. Izumi T., Shimizu T. Platelet-activating factor receptor: gene expression and signal transduction. Biochim. Biophys. Acta. 1259:1995;317.
10. Ishii S., Shimizu T. Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice. Prog. Lipid Res. 39:2000;41.
11. Prescott S.M., Zimmerman G.A., Stafforini D.M., McIntyre T.M. Platelet-activating factor and related lipid mediators. Annu. Rev. Biochem. 69:2000;419.
12. Snyder F. Platelet-activating factor and its analogs: metabolic pathways and related intracellular processes. Biochim. Biophys. Acta. 1254:1995;231.
13. Snyder F. Platelet-activating factor: the biosynthetic and catabolic enzymes. Biochem. J. 305:1995;689.
14. Honda Z., Nakamura M., Miki I., Minami M., Watanabe T., Seyama Y.et al. Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung. Nature. 349:1991;342.
15. Bito H., Honda Z., Nakamura M., Shimizu T. Cloning, expression and tissue distribution of rat platelet-activating-factor-receptor cDNA. Eur. J. Biochem. 221:1994;211.
16. Nakamura M., Honda Z., Izumi T., Sakanaka C., Mutoh H., Minami M.et al. Molecular cloning and expression of platelet-activating factor receptor from human leukocytes. J. Biol. Chem. 266:1991;20400.
17. Kunz D., Gerard N.P., Gerard C. The human leukocyte platelet-activating factor receptor: cDNA cloning, cell surface expression, and construction of a novel epitope-bearing analog. J. Biol. Chem. 267:1992;9101.
18. Ye R.D., Prossnitz E.R., Zou A.H., Cochrane C.G. Characterization of a human cDNA that encodes a functional receptor for platelet activating factor. Biochem. Biophys. Res. Commun. 180:1991;105.
19. Sugimoto T., Tsuchimochi H., McGregor C.G., Mutoh H., Shimizu T., Kurachi Y. Molecular cloning and characterization of the platelet-activating factor receptor gene expressed in the human heart. Biochem. Biophys. Res. Commun. 189:1992;617.
20. Izumi T., Kishimoto S., Takano T., Nakamura M., Miyabe Y., Nakata M.et al. Expression of human platelet-activating factor receptor gene in EoL-1 cells following butyrate-induced differentiation. Biochem. J. 305:1995;829.
21. Mutoh H., Bito H., Minami M., Nakamura M., Honda Z., Izumi T.et al. Two different promoters direct expression of two distinct forms of mRNAs of human platelet-activating factor receptor. FEBS Lett. 322:1993;129.
22. Seyfried C.E., Schweickart V.L., Godiska R., Gray P.W. The human platelet-activating factor receptor gene (PTAFR) contains no introns and maps to chromosome 1. Genomics. 13:1992;832.
23. Chase P.B., Halonen M., Regan J.W. Cloning of a human platelet-activating factor receptor gene: evidence for an intron in the 5′-untranslated region. Am. J. Respir. Cell Mol. Biol. 8:1993;240.
24. Ishii S., Matsuda Y., Nakamura M., Waga I., Kume K., Izumi T.et al. A murine platelet-activating factor receptor gene: cloning, chromosomal localization and up-regulation of expression by lipopolysaccharide in peritoneal resident macrophages. Biochem. J. 314:1996;671.
25. Chase P.B., Yang J.M., Thompson F.H., Halonen M., Regan J.W. Regional mapping of the human platelet-activating factor receptor gene (PTAFR) to 1p35 → p34.3 by fluorescence in situ hybridization. Cytogenet. Cell Genet. 72:1996;205.
26. Abbott C.A., Blank R., Eppig J.T., Fiedorek F.T. Jr., Frankel W., Friedman J.M.et al. Mouse chromosome 4. Mammal Genome. 5:1994;S51.
27. 2+ response between hamster and guinea pig alveolar macrophages. J. Pharmacol. Exp. Ther. 281:1997;1047.
28. Centemeri C., Colli S., Tosarello D., Ciceri P., Nicosia S. Heterogeneous platelet-activating factor (PAF) receptors and calcium increase in platelets and macrophages. Biochem. Pharmacol. 57:1999;263.
29. Fukunaga K., Ishii S., Asano K., Yokomizo T., Shiomi T., Shimizu T.et al. Single nucleotide polymorphism of human platelet-activating factor receptor impairs G-protein activation. J. Biol. Chem. 276:2001;43025.
30. Hanahan D.J., Demopoulos C.A., Liehr J., Pinckard R.N. Identification of platelet activating factor isolated from rabbit basophils as acetyl glyceryl ether phosphocholine. J. Biol. Chem. 255:1980;5514.
31. Mencia-Huerta J.M., Lewis R.A., Razin E., Austen K.F. Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE. J. Immunol. 131:1983;2958.
32. Ikegami K., Hata H., Fuchigami J., Tanaka K., Kohjimoto Y., Uchida S.et al., Tasaka K. Apafant (a PAF receptor antagonist) suppresses the early and late airway responses in guinea pigs: a comparison with antiasthmatic drugs. Eur. J. Pharmacol. 328:1997;75.
33. Miwa M., Miyake T., Yamanaka T., Sugatani J., Suzuki Y., Sakata S.et al. Characterization of serum platelet-activating factor (PAF) acetylhydrolase: correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children. J. Clin. Invest. 82:1988;1983.
34. Stafforini D.M., Satoh K., Atkinson D.L., Tjoelker L.W., Eberhardt C., Yoshida H.et al. Platelet-activating factor acetylhydrolase deficiency: a missense mutation near the active site of an anti-inflammatory phospholipase. J. Clin. Invest. 97:1996;2784.
35. Stafforini D.M., McIntyre T.M., Zimmerman G.A., Prescott S.M. Platelet-activating factor acetylhydrolases. J. Biol. Chem. 272:1997;17895.
36. Stafforini D.M., Numao T., Tsodikov A., Vaitkus D., Fukuda T., Watanabe N.et al. Deficiency of platelet-activating factor acetylhydrolase is a severity factor for asthma. J. Clin. Invest. 103:1999;989.
37. Tsukioka K., Matsuzaki M., Nakamata M., Kayahara H., Nakagawa T. Increased plasma level of platelet-activating factor (PAF) and decreased serum PAF acetylhydrolase (PAFAH) activity in adults with bronchial asthma. J. Investig. Allergol. Clin. Immunol. 6:1996;22.
38. Albert D.H., Magoc T.J., Tapang P., Luo G., Morgan D.W., Curtin M.et al. Pharmacology of ABT-491, a highly potent platelet-activating factor receptor antagonist. Eur. J. Pharmacol. 325:1997;69.
39. Qu X.W., Rozenfeld R.A., Huang W., Crawford S.E., Gonzalez C.F., Hsueh W. Interaction of platelet-activating factor, spleen and atrial natriuretic peptide in plasma volume regulation during endotoxaemia in rats. J. Physiol. 512:1998;227.
40. Cundell D.R., Gerard N.P., Gerard C., Idanpaan H.I., Tuomanen E.I. Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature. 377:1995;435.
41. Ring A., Weiser J.N., Tuomanen E.I. Pneumococcal trafficking across the blood-brain barrier. Molecular analysis of a novel bidirectional pathway. J. Clin. Invest. 102:1998;347.
42. Izaki S., Yamamoto T., Goto Y., Ishimaru S., Yudate F., Kitamura K.et al. Platelet-activating factor and arachidonic acid metabolites in psoriatic inflammation. Br. J. Dermatol. 134:1996;1060.
43. Kemeny L., Trach V., Dobozy A. Effect of locally applied WEB 2086, a platelet-activating factor antagonist, on inflammatory skin conditions in mice. Arch. Dermatol. Res. 288:1996;492.
44. Woodward D.F., Nieves A.L., Spada C.S., Williams L.S., Tuckett R.P. Characterization of a behavioral model for peripherally evoked itch suggests platelet-activating factor as a potent pruritogen. J. Pharmacol. Exp. Ther. 272:1995;758.
45. Hattori M., Adachi H., Tsujimoto M., Arai H., Inoue K. Miller-Dieker lissencephaly gene encodes a subunit of brain platelet-activating factor acetylhydrolase. Nature. 370:1994;216.
46. Hirotsune S., Fleck M.W., Gambello M.J., Bix G.J., Chen A., Clark G.D.et al. Graded reduction of Pafah1b1 (Lis1) activity results in neuronal migration defects and early embryonic lethality. Nat. Genet. 19:1998;333.
47. Ishii S., Nagase T., Tashiro F., Ikuta K., Sato S., Waga I.et al. Bronchial hyperreactivity, increased endotoxin lethality and melanocytic tumorigenesis in transgenic mice overexpressing platelet-activating factor receptor. EMBO J. 16:1997;133.
48. Araki K., Araki M., Miyazaki J., Vassalli P. Site-specific recombination of a transgene in fertilized eggs by transient expression of Cre recombinase. Proc. Natl. Acad. Sci. U.S.A. 92:1995;160.
49. Sunaga S., Maki K., Komagata Y., Ikuta K., Miyazaki J.I. Efficient removal of loxP-flanked DNA sequences in a gene-targeted locus by transient expression of Cre recombinase in fertilized eggs. Mol. Reprod. Dev. 46:1997;109.
50. Sakai K., Miyazaki J.I. A transgenic mouse line that retains Cre recombinase activity in mature oocytes irrespective of the cre transgene transmission. Biochem. Biophys. Res. Commun. 237:1997;318.
51. Ishii S., Kuwaki T., Nagase T., Maki K., Tashiro F., Sunaga S.et al. Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor. J. Exp. Med. 187:1998;1779.
52. Aihara M., Ishii S., Kume K., Shimizu T. Interaction between neurone and microglia mediated by platelet-activating factor. Genes Cells. 5:2000;397.
53. + channel, TASK-1, contributes to the arrhythmogenic effects of platelet-activating factor. Am J Physiol 2002;282:2024.
54. Wu C., Stojanov T., Chami O., Ishii S., Shimizu T., Li A.et al. Evidence for the autocrine induction of capacitation of mammalian spermatozoa. J. Biol. Chem. 276:2001;26962.
55. Nagase T., Ishii S., Katayama H., Fukuchi Y., Ouchi Y., Shimizu T. Airway responsiveness in transgenic mice overexpressing platelet-activating factor receptor: roles of thromboxanes and leukotrienes. Am. J. Respir. Crit. Care Med. 156:1997;1621.
56. Nagase T., Ishii S., Shindou H., Ouchi Y., Shimizu T. Airway hyperresponsiveness in transgenic mice overexpressing platelet activating factor receptor is mediated by an atropine-sensitive pathway. Am. J. Respir. Crit. Care Med. 165:2002;200.
57. Wu T., Rieves R.D., Logun C., Shelhamer J.H. Platelet-activating factor stimulates eicosanoid production in cultured feline tracheal epithelial cells. Lung. 173:1995;89.
58. Gomez F.P., Iglesia R., Roca J., Barbera J.A., Chung K.F., Rodriguez- Roisin R. The effects of 5-lipoxygenase inhibition by zileuton on platelet-activating-factor-induced pulmonary abnormalities in mild asthma. Am. J. Respir. Crit. Care Med. 157:1998;1559.
59. Nagase T., Ishii S., Kume K., Uozumi N., Izumi T., Ouchi Y.et al. Platelet-activating factor mediates acid-induced lung injury in genetically-engineered mice. J. Clin. Invest. 104:1999;1071.
60. Koltai M., Hosford D., Braquet P. PAF-induced amplification of mediator release in septic shock: prevention or downregulation by PAF antagonists. J. Lipid Mediat. 6:1993;183.
61. Kobayashi K., Ishii S., Kume K., Takahashi T., Shimizu T., Manabe T. Platelet-activating factor receptor is not required for long-term potentiation in the hippocampal CA1 region. Eur. J. Neurosci. 11:1999;1313.
62. Chen C., Magee J.C., Marcheselli V., Hardy M., Bazan N.G. Attenuated LTP in hippocampal dentate gyrus neurons of mice deficient in the PAF receptor. J. Neurophysiol. 85:2001;384.
63. Sato S., Kume K., Ito C., Ishii S., Shimizu T. Accelerated proliferation of the epidermal keratinocytes by the transgenic expression of the platelet-activating factor receptor. Arch. Dermatol. Res. 291:1999;614.
64. Halaban R., Langdon R., Birchall N., Cuono C., Baird A., Scott G.et al. Basic fibroblast growth factor from human keratinocytes is a natural mitogen for melanocytes. J. Cell Biol. 107:1988;1611.
65. Imokawa G., Miyagishi M., Yada Y. Endothelin-1 as a new melanogen: coordinated expression of its gene and the tyrosinase gene in UVB-exposed human epidermis. J. Invest. Dermatol. 105:1995;32.
66. Grabbe J., Welker P., Dippel E., Czarnetzki B.M. Stem cell factor, a novel cutaneous growth factor for mast cells and melanocytes. Arch. Dermatol. Res. 287:1994;78.
67. Ishibashi S., Brown M.S., Goldstein J.L., Gerard R.D., Hammer R.E., Herz J. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J. Clin. Invest. 92:1993;883.
68. Gurney A.L., Carver-Moore K., de Sauvage F.J., Moore M.W. Thrombocytopenia in c-mpl-deficient mice. Science. 265:1994;1445.
69. Shindou H., Ishii S., Uozumi N., Shimizu T. Roles of cytosolic phospholipase A2 and platelet-activating factor receptor in the Ca-induced biosynthesis of PAF. Biochem. Biophys. Res. Commun. 271:2000;812.
70. Ohshima N, Ishii S, Izumi T, Shimizu T. Receptor-dependent metabolism of platelet-activating factor in murine macrophages. J Biol Chem 2002;277:9722.
71. Saeed S.A., Simjee R.U., Mahmood F., Rahman N.N. Dual inhibition of platelet-activating factor and arachidonic acid metabolism by ajmaline and effect on carrageenan-induced rat paw oedema. J. Pharm. Pharmacol. 45:1993;715.
72. Hsiao G., Ko F.N., Jong T.T., Teng C.M. Antiplatelet action of 3′,4′-diisovalerylkhellactone diester purified from Peucedanum japonicum. Thunb. Biol. Pharm. Bull. 21:1998;688.
73. Le Texier L., Favre E., Redeuilh C., Blavet N., Bellahsene T., Dive G.et al. Structure-activity relationships in platelet-activating factor (PAF). 7. Tetrahydrofuran derivatives as dual PAF antagonists and acetylcholinesterase inhibitors: synthesis and PAF-antagonistic activity. J. Lipid Mediat. Cell Signal. 13:1996;189.
74. Svetlov S.I., Howard K.M., Miwa M., Flickinger B.D., Olson M.S. Interaction of platelet-activating factor with rat hepatocytes: uptake, translocation, metabolism, and effects on PAF-acetylhydrolase secretion and protein tyrosine phosphorylation. Arch. Biochem. Biophys. 327:1996;113.
75. Adachi T., Aoki J., Manya H., Asou H., Arai H., Inoue K. PAF analogues capable of inhibiting PAF acetylhydrolase activity suppress migration of isolated rat cerebellar granule cells. Neurosci. Lett. 235:1997;133.
76. Piwinski J.J., Wong J.K., Green M.J., Ganguly A.K., Billah M.M., West R.J.et al. Dual antagonists of platelet activating factor and histamine: identification of structural requirements for dual activity of N-acyl-4-(5,6-dihydro-11H-benzo [5,6]cyclohepta-[1,2-b]pyridin-11-ylidene)piperidines. J. Med. Chem. 34:1991;457.
77. Billah M.M., Egan R.W., Ganguly A.K., Green M.J., Kreutner W., Piwinski J.J.et al. Discovery and preliminary pharmacology of Sch 37370, a dual antagonist of PAF and histamine. Lipids. 26:1991;1172.
78. Merlos M., Giral M., Balsa D., Ferrando R., Queralt M., Puigdemont A.et al. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF). J. Pharmacol. Exp. Ther. 280:1997;114.